Allurion Technologies, Inc.: First Multi-Center Study Combining the Allurion Program With GLP-1 Therapy Presented at the European Congress on Obesity
Combination therapy led to nearly 19% weight loss at approximately 8 months Allurion, a company dedicated to ending obesity, today announced results from a new study that will be presented at the
Source: finanznachrichten.de